Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells

    At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…

    April 14, 2022| Arthur N. Brodsky, PhD
  • Ira Mellman Receives 2022 AACR-CRI Lloyd J. Old Award in Cancer Immunology

    Dr. Ira Mellman, a longtime member of the CRI Scientific Advisory Council, received CRI’s highest scientific career…

    April 1, 2022| Arthur N. Brodsky, PhD
  • Mining the Mysteries of Myeloid Cells with CRI Lloyd J. Old STAR Malay Haldar

    CRI Lloyd J. Old STAR Malay Haldar is exploring the role of dendritic cells and macrophages in…

    March 28, 2022| Arthur N. Brodsky, PhD
  • ASCO18 Update: Immunotherapy Progress in Lung Cancer, New Promise in Ovarian Cancer

    Day 3 of ASCO18 revealed more of immunotherapy’s benefits in lung cancer, especially as a first-line option,…

    June 4, 2018| Arthur N. Brodsky, PhD
  • AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells

    Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…

    April 18, 2018| Arthur N. Brodsky, PhD

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal